Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 23, 2024

BUY
$56.27 - $73.77 $346,229 - $453,906
6,153 New
6,153 $424,000
Q4 2023

Feb 09, 2024

SELL
$59.06 - $75.72 $53,449 - $68,526
-905 Reduced 12.82%
6,153 $455,000
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $16,485 - $24,760
250 Added 3.67%
7,058 $481,000
Q1 2023

May 11, 2023

BUY
$47.19 - $70.77 $176,962 - $265,387
3,750 Added 122.63%
6,808 $461,000
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $92,810 - $162,532
3,058 New
3,058 $151,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Wellington Shields & Co., LLC Portfolio

Follow Wellington Shields & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields & Co., LLC with notifications on news.